|
1
|
Kademani D: Oral cancer. Mayo Clin Proc.
82:878–887. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Petersen PE: Oral cancer prevention and
control - the approach of the World Health Organization. Oral
Oncol. 45:454–460. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barnes L, Eveson JW, Reichart P and
Sidransky D: Tumours of the oral cavity and oropharynx. World
Health Organization Classification of Tumours: Pathology and
Genetics of Head and Neck Tumours. 9:(3rd). (Lyon, France). IARC
Press. 166–210. 2005.
|
|
4
|
Chen GS and Chen CH: A study on survival
rates of oral squamous cell carcinoma. Kaohsiung J Med Sci.
12:317–325. 1996.(In Chinese). PubMed/NCBI
|
|
5
|
Lim YC and Choi EC: Surgery alone for
squamous cell carcinoma of the oral cavity: survival rates,
recurrence patterns, and salvage treatment. Acta Otolaryngol.
128:1132–1137. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lo Muzio L, Campisi G, Farina A, et al:
P-cadherin expression and survival rate in oral squamous cell
carcinoma: an immunohistochemical study. BMC Cancer. 5:632005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Blot WJ, McLaughlin JK, Winn DM, et al:
Smoking and drinking in relation to oral and pharyngeal cancer.
Cancer Res. 48:3282–3287. 1988.PubMed/NCBI
|
|
8
|
Ruiz Figuero E, Peláez Carretero MA,
Lapiedra Cerero R, Gómez Esparza G and López Moreno LA: Effects of
the consumption of alcohol in the oral cavity: relationship with
oral cancer. Med Oral. 9:14–23. 2004.PubMed/NCBI
|
|
9
|
Johnson N: Tobacco use and oral cancer: a
global perspective. J Dent Educ. 65:328–339. 2001.PubMed/NCBI
|
|
10
|
Zhang Y, Ni Y, Zhang H, Pan Y, Ma J and
Wang L: Association between GSTM1 and GSTT1 allelic variants and
head and neck squamous cell cancinoma. PLoS One. 7:e475792012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Y, Yang H, Li L and Wang H:
Glutathione S-transferase T1 gene deletion polymorphism and lung
cancer risk in Chinese population: a meta-analysis. Cancer
Epidemiol. 34:593–597. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pei YL, Zhang HL and Han HG: Polymorphism
of 8q24 rsl3281615 and breast cancer risk: a meta-analysis. Tumor
Biol. 34:421–428. 2013. View Article : Google Scholar
|
|
13
|
Ji YN, Wang Q and Suo LJ: CYP1A1 Ile462Val
polymorphism contributes to lung cancer susceptibility among lung
squamous carcinoma and smokers: a meta-analysis. PloS One.
7:e433972012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hashibe M, Brennan P, Strange RC, et al:
Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1
genotypes and risk of head and neck cancer. Cancer Epidemiol
Biomarkers Prev. 12:1509–1517. 2003.PubMed/NCBI
|
|
15
|
Feng X, Zhou H-F, Zheng B-S, Shi J-J, Luo
C and Qin J-J: Association of glutathione S-transferase P1 gene
polymorphism with the histological types of lung cancer: a
meta-analysis. Mol Biol Rep. 40:2439–2447. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tanimoto K, Hayashi S, Yoshiga K and
Ichikawa T: Polymorphisms of the CYP1A1 and GSTM1 gene involved in
oral squamous cell carcinoma in association with a cigarette dose.
Oral Oncol. 35:191–196. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shukla D, Kale Dinesh A, Hallikerimath S,
Vivekanandhan S and Venkatakanthaiah Y: Genetic polymorphism of
drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for
oral premalignant lesions and oral cancer. Biomed Pap Med Fac Univ
Palacky Olomouc Czech Repub. 156:253–259. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sato M, Sato T, Izumo T and Amagasa T:
Genetic polymorphism of drug-metabolizing enzymes and
susceptibility to oral cancer. Carcinogenesis. 20:1927–1931. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sam SS, Thomas V, Reddy KS, Surianarayanan
G and Chandrasekaran A: CYP1A1 polymorphisms and the risk of upper
aerodigestive tract cancers in an indian population. Head Neck.
30:1566–1574. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Losi-Guembarovski R, Cólus IM, De Menezes
RP, et al: Lack of association among polymorphic
xenobiotic-metabolizing enzyme genotypes and the occurrence and
progression of oral carcinoma in a brazilian population. Anticancer
Res. 28:1023–1028. 2008.PubMed/NCBI
|
|
21
|
Kao SY, Wu CH, Lin SC, et al: Genetic
polymorphism of cytochrome P4501A1 and susceptibility to oral
squamous cell carcinoma and oral precancer lesions associated with
smoking/betel use. J Oral Pathol Med. 31:505–511. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gronau S, Koenig-Greger D, Jerg M and
Riechelmann H: GSTM1 enzyme concentration and enzyme activity in
correlation to the genotype of detoxification enzymes in squamous
cell carcinoma of the oral cavity. Oral Dis. 9:62–67. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gattás GJ, de Carvalho MB, Siraque MS, et
al: Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1
associated with head and neck cancer. Head Neck. 28:819–826. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cha IH, Park JY, Chung WY, Choi MA, Kim HJ
and Park KK: Polymorphisms of CYP1A1 and GSTM1 genes and
susceptibility to oral cancer. Yonsei Med J. 48:233–239. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Anantharaman D, Chaubal PM, Kannan S,
Bhisey RA and Mahimkar MB: Susceptibility to oral cancer by genetic
polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among indians:
tobacco exposure as a risk modulator. Carcinogenesis. 28:1455–1462.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bartsch H, Nair U, Risch A, Rojas M,
Wikman H and Alexandrov K: Genetic polymorphism of CYP genes, alone
or in combination, as a risk modifier of tobacco-related cancers.
Cancer Epidemiol Biomarkers Prev. 9:3–28. 2000.PubMed/NCBI
|
|
27
|
Petersen DD, McKinney CE, Ikeya K, et al:
Human CYP1A1 gene: cosegregation of the enzyme inducibility
phenotype and an RFLP. Am J Hum Genet. 48:720–725. 1991.PubMed/NCBI
|
|
28
|
Landi MT, Bertazzi PA, Shields PG, et al:
Association between CYP1A1 genotype, mRNA expression and enzymatic
activity in humans. Pharmacogenetics. 4:242–246. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou SF, Liu JP and Chowbay B:
Polymorphism of human cytochrome P450 enzymes and its clinical
impact. Drug Metab Rev. 41:89–295. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wells GA, Shea B, O'Connell D, Peterson J,
Welch V, Losos M and Tugwell P: The Newcastle-Ottawa scale (NOS)
for assessing the quality of nonrandomised studies in
meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.aspAccessed.
February 03–2016
|
|
31
|
Stang A: Critical evaluation of the
Newcastle-Ottawa scale for the assessment of the quality of
nonrandomized studies in meta-analyses. Eur J Epidemiol.
25:603–605. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cochran WG: The combination of estimates
from different experiments. Biometrics. 10:101–129. 1954.
View Article : Google Scholar
|
|
33
|
Egger M, Smith Davey G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Matthias C, Bockmühl U, Jahnke V, Harries
LW, Wolf CR, et al: The glutathione S-transferase GSTP1
polymorphism: effects on susceptibility to oral/pharyngeal and
laryngeal carcinomas. Pharmacogenetics. 8:1–6. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Khlifi R, Messaoud O, Rebai A and
Hamza-Chaffai A: Polymorphisms in the human cytochrome P450 and
arylamine N-Acetyltransferase: susceptibility to head and neck
cancers. Biomed Res Int. 2013:5827682013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu L, Wu G, Xue F, et al: Functional
CYP1A1 genetic variants, alone and in combination with smoking,
contribute to development of head and neck cancers. Eur J Cancer.
49:2143–2151. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ruwali M and Parmar D: Association of
functionally important polymorphisms in cytochrome P450s with
squamous cell carcinoma of head and neck. Indian J Exp Biol.
48:651–665. 2010.PubMed/NCBI
|
|
38
|
Amtha R, Ching CS, Zain R, et al: GSTM1,
GSTT1 and CYP1A1 polymorphisms and risk of oral cancer: a
case-control study in Jakarta, Indonesia. Asian Pac J Cancer Prev.
10:21–26. 2009.PubMed/NCBI
|
|
39
|
Buch SC, Nazar-Stewart V, Weissfeld JL and
Romkes M: Case-control study of oral and oropharyngeal cancer in
whites and genetic variation in eight metabolic enzymes. Head Neck.
30:1139–1147. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Katoh T: Application of molecular biology
to occupational health field - the frequency of gene polymorphism
of cytochrome P450 1A1 and glutathione S-transferase M1 in patients
with lung, oral and urothelial cancer. J UOEH. 17:271–278. 1995.(In
Japanese). PubMed/NCBI
|
|
41
|
Katoh T, Kaneko S, Kohshi K, et al:
Genetic polymorphisms of tobacco- and alcohol-related metabolizing
enzymes and oral cavity cancer. Int J Cancer. 83:606–609. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Marques CF, Koifman S, Koifman RJ,
Boffetta P, Brennan P and Hatagima A: Influence of cyp1a1, CYP2E1,
GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility:
results from a case-control study in Rio de Janeiro. Oral Oncol.
42:632–637. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sugimura T, Kumimoto H, Tohnai I, et al:
Gene-environment interaction involved in oral carcinogenesis:
molecular epidemiological study for metabolic and DNA repair gene
polymorphisms. J Oral Pathol Med. 35:11–18. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shukla D, Kale AD, Hallikerimath S,
Yerramalla V, Subbiah V and Mishra S: Association between GSTM1 and
CYP1A1 polymorphisms and survival in oral cancer patients. Biomed
Pap Med Fac Univ Palacky Olomouc Czech Repub. 157:304–310.
2013.PubMed/NCBI
|
|
45
|
Anantharaman D, Samant TA, Sen S and
Mahimkar MB: Polymorphisms in tobacco metabolism and DNA repair
genes modulate oral precancer and cancer risk. Oral Oncol.
47:866–872. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Boccia S, Cadoni G, Sayed-Tabatabaei FA,
et al: CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2
polymorphisms, smoking, consumption of alcohol and fruit and
vegetables and risk of head and neck cancer. J Cancer Res Clin
Oncol. 134:93–100. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Canova C, Richiardi L, Merletti F, et al:
Alcohol, tobacco and genetic susceptibility in relation to cancers
of the upper aerodigestive tract in northern Italy. Tumori.
96:1–10. 2010.PubMed/NCBI
|
|
48
|
Cury NM, Russo A, Galbiatti ALS, et al:
Polymorphisms of the CYP1A1 and CYP2E1 genes in head and neck
squamous cell carcinoma risk. Mol Biol Rep. 39:1055–1063. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ko Y, Abel J, Harth V, et al: Association
of CYP1B1 codon 432 mutant allele in head and neck squamous cell
cancer is reflected by somatic mutations of p53 in tumor tissue.
Cancer Res. 61:4398–4404. 2001.PubMed/NCBI
|
|
50
|
Olivieri EH, da Silva SD, Mendonca FF, et
al: CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of
risk and poor outcome in head and neck squamous cell carcinoma
patients. Oral Oncol. 45:e73–e79. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ramadas K, Ramachandran S, Muwonge R and
Pillai MR: Tumor progression in the oral cavity: The significance
of genetic polymorphisms in CYP1A1, GST M1 and XRCC1 in a south
Indian population. Oral Oncol Supplement. (Suppl 3): 69. 2009.
View Article : Google Scholar
|
|
52
|
Sabitha K, Reddy MV and Jamil K: Smoking
related risk involved in individuals carrying genetic variants of
CYP1A1 gene in head and neck cancer. Cancer Epidemiol. 34:587–592.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Sam SS, Thomas V, Reddy KS, Surianarayanan
G and Chandrasekaran A: Gene-gene interactions of drug metabolizing
enzymes and transporter protein in the risk of upper aerodigestive
tract cancers among indians. Cancer Epidemiol. 34:626–633. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sam SS, Thomas V, Reddy KS, Surianarayanan
G and Chandrasekaran A: Gene-environment interactions associated
with CYP1A1 Mspi and GST polymorphisms and the risk of upper
aerodigestive tract cancers in an indian population. J Cancer Res
Clin Oncol. 136:945–951. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sharma R, Ahuja M, Panda NK and Khullar M:
Combined effect of smoking and polymorphisms in tobacco
carcinogen-metabolizing enzymes CYP1A1 and GSTM1 on the head and
neck cancer risk in North Indians. DNA Cell Biol. 29:441–448. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Sharma R, Ahuja M, Panda NK and Khullar M:
Interactions among genetic variants in tobacco metabolizing genes
and smoking are associated with head and neck cancer susceptibility
in North Indians. DNA Cell Biol. 30:611–616. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Sharma R, Panda NK and Khullar M:
Hypermethylation of carcinogen metabolism genes, CYP1A1, CYP2A13
and GSTM1 genes in head and neck cancer. Oral Dis. 16:668–673.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Singh AP, Shah PP, Ruwali M, Mathur N,
Pant MC and Parmar D: Polymorphism in cytochrome P4501A1 is
significantly associated with head and neck cancer risk. Cancer
Invest. 27:869–876. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yadav SS, Ruwali M, Pant MC, Shukla P,
Singh RL and Parmar D: Interaction of drug metabolizing cytochrome
P450 2D6 poor metabolizers with cytochrome P450 2C9 and 2C19
genotypes modify the susceptibility to head and neck cancer and
treatment response. Mutat Res. 684:49–55. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Chatterjee S, Dhar S, Sengupta B, et al:
Polymorphisms of CYP1A1, GSTM1 and GSTT1 loci as the genetic
predispositions of oral cancers and other oral pathologies: tobacco
and alcohol as risk modifiers. Indian J Clin Biochem. 25:260–272.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Cordero K, Espinoza I, Caceres D, et al:
Oral cancer susceptibility associated with the CYP1A1 and GSTM1
genotypes in Chilean individuals. Oncol Lett. 1:549–553.
2010.PubMed/NCBI
|
|
62
|
Guo L, Zhang C, Shi S and Guo X:
Correlation between smoking and the polymorphisms of cytochrome
P450 1A1-Msp I and glutathione s-transferase T1 genes and oral
cancer. Hua Xi Kou Qiang Yi Xue Za Zhi. 30:187–191. 2012.(In
Chinese). PubMed/NCBI
|
|
63
|
Masood N, Kayani MA, Malik FA, Mahjabeen
I, Baig RM and Faryal R: Genetic variations in carcinogen
metabolizing genes associated with oral cancer in pakistani
population. Asian Pac J Cancer Prev. 12:491–495. 2011.PubMed/NCBI
|
|
64
|
Matthias C, Bockmühl U, Jahnke V, et al:
Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and
glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility
to tobacco-related cancers: studies in upper aerodigestive tract
cancers. Pharmacogenetics. 8:91–100. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Chatterjee S, Chakrabarti S, Sengupta B,
et al: Prevalence of CYP1A1 and GST polymorphisms in the population
of northeastern India and susceptibility of oral cancer. Oncol Res.
17:397–403. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Zhan P, Wang Q, Qian Q, Wei S-Z and Yu
L-K: CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk:
an updated meta-analysis and review. J Exp Clin Cancer Res.
30:992011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zhuo W, Wang Y, Zhuo X, et al: CYP1A1 and
GSTM1 polymorphisms and oral cancer risk: association studies via
evidence-based meta-analyses. Cancer Invest. 27:86–95. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Zhuo X, Zhao H, Chang A, et al:
Quantitative assessment of CYP1A1*2A variations with oral carcinoma
susceptibility: evidence from 1,438 cases and 2,086 controls.
Cancer Invest. 30:552–559. 2012. View Article : Google Scholar : PubMed/NCBI
|
